EECP Therapy Effectively Improves Functional Capacity in Chronic Heart Failure Patients 體外反搏有效改善慢性心臟衰竭患者的心臟 功能能力

Source From 資料來源 : https://pubmed.ncbi.nlm.nih.gov/26932695/

EECP Therapy Effectively Improves Functional Capacity in Chronic Heart Failure Patients

AIM:

To investigate the efficacy of enhanced external counterpulsation (EECP) therapy to improve functional capacity in patients with chronic heart failure (CHF).

METHODS:

A double-blind random clinical trial was performed in 99 patients with CHF who had received EECP therapy at Jade Cardiovascular Clinic, Manado, North Sulawesi, Indonesia between January 2014 and June 2015. Subjects were categorized into 2 groups, i.e. 49 subjects had sham EECP therapy and 50 subjects had EECP therapy. All subjects performed six-minute walking test (6MWT) before and after receiving EECP therapy.

RESULTS:

There was no significant difference between both groups regarding the basic characteristics of patients with CHF. The 6MWT result before EECP therapy showed that there were 30 patients (61.2%) with walk distance of <300 meter in the sham EECP group; while in the group receiving EECP therapy, we found 34 patients (68%); p=0.24. Post-EECP therapy, there were 33 patients (67.3%) with walk distance of <300 meters in EECP sham group; while in the group receiving EECP alone, there was only 1 patient (2%); p<0.01. The 6MWT walk distance in sham group before EECP therapy was 252.65 (SD 97.55) meters and it was 243.65 (SD 86.96) meters following the EECP therapy; p=0.18. In EECP group, the 6MWT walk distance before therapy was 256.88 (SD 85.56) meters and after EECP therapy the walk distance was 449.46 (SD 92.08) meters; p<0.01.

CONCLUSION:

EECP therapy is effective to improve functional capacity in patients with CHF.

「增強體外反搏療法對慢性心力衰竭患者 功能能力 的影響和改善:一項隨機臨床試驗」

目的

探究體外反搏(EECP)治療對慢性心臟衰竭(CHF)患者的 功能能力 改善的療效。

方法

在印尼北蘇拉威西省馬納多的Jade心血管診所,於2014年1月至2015年6月間,對99名接受EECP治療的CHF患者進行了一項雙盲隨機臨床試驗。受試者被分為兩組,即49名受試者接受假EECP治療,50名受試者接受EECP治療。所有受試者在接受EECP治療前後均進行了六分鐘步行測試(6MWT)。

結果

就CHF患者的基本特徵而言,兩組之間沒有顯著差異。在EECP治療前的6MWT結果中,假EECP組中有30名患者(61.2%)的步行距離小於300米,而接受EECP治療的組中有34名患者(68%)。在接受EECP治療後,假EECP治療組中有33名患者(67.3%)的步行距離小於300米,而在EECP治療組,僅有1名患者(2%)步距少於300米。在假EECP治療組中,EECP治療前的6MWT步行距離為252.65米,治療後為243.65米。而在EECP治療組中,治療前的6MWT步行距離為256.88米,治療後的步行距離增加至449.46米。

結論

EECP治療對改善CHF患者的心臟 功能能力 具有療效。

×